SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 25, 12:12
3069.90
30.8 (1.01%)
VOLUME 18,474
LIVE
NSE
Aug 25, 12:12
3065.80
26 (0.86%)
VOLUME 166,012
News on Dr Reddys Laboratories
Select Year: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Expect volatile day; buy weakness, sell strength: Rajat Bose

8.21 am | 25 Aug 2016 |  Source: Moneycontrol.com

Rajat Bose, Research Analyst at rajatkbose.com expects a volatile day for Nifty while one can adopt a buy-weakness-sell-strength trading strategy....

Positive on LIC Housing, HDFC; sell Dr Reddy's, HUL: Experts

7.42 am | 23 Aug 2016 |  Source: CNBC-TV18

Neelkanth Mishra of Credit Suisse remains positive on LIC Housing Finance, HDFC and Indiabulls Housing Finance. Top sells are Dr Reddy's Labs, HCL Tec...

Keep HDFC in portfolio: Vijay Chopra 

3.46 pm | 18 Aug 2016 |  Source: CNBC-TV18

Vijay Chopra of enochventures.com is of the view that one may keep HDFC in portfolio....

Prefer HDFC, says Rajat Bose 

3.43 pm | 18 Aug 2016 |  Source: CNBC-TV18

Rajat Bose of rajatkbose.com is of the view that one may prefer HDFC....

Fund manager's hits and misses from Q1 earnings 

4.14 pm | 16 Aug 2016 |  Source: CNBC-TV18

In an interview with CNBC-TV18, Rajesh Kothari of AlfAccurate Advisors talked about the hits and misses from the first quarter earnings season, includ...

'Market fraught with risk but stay with liquidity gravy train' 

9.46 am | 11 Aug 2016 |  Source: CNBC-TV18

The price action seen in the stock market suggests it is tiring but traders should respect the screen and stay on the "liquidity gravy train" or they ...

Why smart money is leaving mutual funds: Sundaram CEO 

2.51 pm | 10 Aug 2016 |  Source: CNBC-TV18

The monthly average for inflow in equity mutual funds stood at 2015 Rs 7550 crore, where for the first seven months of 2016 it stands at Rs 2293 crore...

Buy Dr Reddy's Labs, Cipla, Biocon: Sanjiv Bhasin 

9.52 pm | 09 Aug 2016 |  Source: CNBC-TV18

Sanjiv Bhasin of IIFL recommends buying Dr Reddy's Labs, Cipla and Biocon....

Pharma, financials, auto best stock performers over 20 years

9.22 am | 09 Aug 2016 |  Source: PTI

According to financial services firm Centrum, some of the long-term outperformers have been Sun Pharma, HDFC Bank, Dr Reddy's, Hero MotoCorp, Britanni...

Dr Reddy's completes acquisition of product portfolio from TEVA

8.29 am | 04 Aug 2016 |  Source: Moneycontrol.com

Dr Reddy's Laboratories has successfully completed the previously announced acquisition of eight ANDAs in the US from Teva Pharmaceuticals Industries ...

Dr Reddy's completes acquisition of 8 ANDAs from Teva Pharma

12.28 am | 04 Aug 2016 |  Source: PTI

Dr Reddy's Laboratories today said it has successfully completed the USD 350 million (around Rs 2,300 crore) acquisition of eight abbreviated new dr...

Cipla appoints Kedar Upadhye as Global CFO

1.10 pm | 01 Aug 2016 |  Source: PTI

Until recently, Kedar was Vice President, Global Generics Finance and Head of Investor Relations in Dr Reddy's Laboratories, Cipla said in a statement...

One should be a paranoid bull right now: Udayan Mukherjee 

9.47 am | 01 Aug 2016 |  Source: CNBC-TV18

Speaking to CNBC-TV18, Consulting Editor Udayan Mukherjee said marquee companies have been disappointing so far in the first quarter of FY17. The tra...

Andrew Holland bets on pharma, says GST is already priced in 

12.00 pm | 30 Jul 2016 |  Source: CNBC-TV18

Speaking to CNBC-TV18, Andrew Holland, CEO of Ambit Investment Advisors said that it is a liquidity market right now. ...

Accumulate Dr. Reddy’s Lab; target of Rs 3,366: KRChoksey

4.22 pm | 29 Jul 2016 |  Source: Moneycontrol.com

KRChoksey is bullish on Dr. Reddy’s Laboratories has recommended accumulate rating on the stock with a target price of Rs 3,366 in its research repo...

DRL, Cipla, Aurobindo among others to buy products from Teva

3.33 pm | 29 Jul 2016 |  Source: PTI

According to a statement issued by US FTC, Teva has agreed to sell the rights and assets related to 79 pharmaceutical products to settle FTC charges...

Six in Sixty: Stocks you should keep on your radar 

3.22 pm | 29 Jul 2016 |  Source: CNBC-TV18

CNBC-TV18's Ekta Batra lists out stocks that you should focus on - ICICI Bank, Larsen & Toubro, Eicher Motors, Tata Steel, Tata Power, Bharti Infratel...

Sell Dr Reddy's; target of Rs 2650: Axis Direct

1.35 pm | 29 Jul 2016 |  Source: Moneycontrol.com

Axis Direct is bearish on Dr Reddy's has recommended sell rating on the stock with a target price of Rs 2650, in its research report dated July 27, 20...

Sell Dr Reddys; target of Rs 2800: Religare

12.49 pm | 29 Jul 2016 |  Source: Moneycontrol.com

Religare is bearish on Dr Reddys has recommended sell rating on the stock with a target price of Rs 2800 in its research report dated July 27, 2016....

NMDC positional buy, stay with Dr Reddy's Labs: Sukhani 

10.58 am | 28 Jul 2016 |  Source: CNBC-TV18

According to Sudarshan Sukhani of s2analytics.com, NMDC positional buy and feels that one can stay with Dr Reddy's Labs. ...

1 2 3 4 5 6
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.